Used as a key intermediate in the synthesis of boron-containing pharmaceuticals, particularly in the development of protease inhibitors and boron neutron capture therapy (BNCT) agents. Its boronic acid group enables reversible interactions with biological targets such as enzymes, making it valuable in designing enzyme inhibitors. Also employed in Suzuki-Miyaura cross-coupling reactions as a building block for biaryl compounds in medicinal chemistry. Its carboxylic acid functionality allows for further derivatization, enhancing its utility in drug design and bioconjugation.